Bayer sees growth in animal health; Merck launches first transdermal BRD drug;

> Bayer announced that third-quarter sales in its animal health division rose 4.1% to €330 million ($415.2 million), led by sales of Advantage and Seresto flea and tick products. Release

> Merck ($MRK) Animal Health launched Finadyne Transdermal, the first transdermal drug to reduce fever associated with with bovine respiratory disease (BRD). Release

> The Canadian pet market has seen sales growth of 4% a year for the past 5 years, driven largely by investments in animal health by players like Bayer and Perrigo ($PRGO), according to a new report from Packaged Facts. Release